| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.864 | 1.675 | 5.716 | 4.924 | 6.542 | 7.655 | 10.865 | 14.341 |
| Total Income - EUR | - | - | 17.809 | 1.675 | 5.716 | 4.924 | 6.542 | 7.655 | 10.865 | 14.342 |
| Total Expenses - EUR | - | - | 7.306 | 295 | 978 | 2.470 | 2.476 | 6.776 | 8.243 | 11.620 |
| Gross Profit/Loss - EUR | - | - | 10.503 | 1.379 | 4.738 | 2.454 | 4.065 | 878 | 2.622 | 2.722 |
| Net Profit/Loss - EUR | - | - | 10.059 | 1.329 | 4.566 | 2.318 | 3.869 | 649 | 1.948 | 1.821 |
| Employees | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lgm Medbest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 469 | 1.067 | 574 | 196 |
| Current Assets | - | - | 10.102 | 1.560 | 4.664 | 2.542 | 3.607 | 1.163 | 2.610 | 2.199 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 5.911 | 565 | 0 | 5 | 5 | 1.066 | 895 | 412 |
| Cash | - | - | 4.192 | 995 | 4.664 | 2.537 | 3.602 | 97 | 1.715 | 1.786 |
| Shareholders Funds | - | - | 10.102 | 1.381 | 4.617 | 2.505 | 3.917 | 697 | 2.643 | 1.869 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 179 | 47 | 37 | 158 | 1.532 | 544 | 526 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Lgm Medbest Srl